Kamada Ltd. (KMDA)
8.43
+0.19
(+2.31%)
USD |
NASDAQ |
Aug 24, 16:00
8.43
0.00 (0.00%)
After-Hours: 07:44
Kamada Price : 8.43 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 8.315 | 8.594 | 8.315 | 8.43 | 198829.0 |
| Aug 21, 2026 | 8.02 | 8.25 | 8.02 | 8.24 | 112865.0 |
| Aug 20, 2026 | 7.83 | 8.13 | 7.80 | 8.02 | 233404.0 |
| Aug 19, 2026 | 7.83 | 7.92 | 7.78 | 7.89 | 265112.0 |
| Aug 18, 2026 | 7.65 | 7.89 | 7.58 | 7.89 | 277801.0 |
| Aug 17, 2026 | 7.53 | 7.865 | 7.51 | 7.76 | 353815.0 |
| Aug 14, 2026 | 7.36 | 7.58 | 7.35 | 7.58 | 244404.0 |
| Aug 13, 2026 | 7.06 | 7.33 | 7.06 | 7.26 | 98833.00 |
| Aug 12, 2026 | 7.09 | 7.21 | 6.85 | 6.88 | 466507.0 |
| Aug 11, 2026 | 7.10 | 7.18 | 7.09 | 7.09 | 53130.00 |
| Aug 10, 2026 | 7.12 | 7.36 | 7.05 | 7.14 | 130138.0 |
| Aug 07, 2026 | 7.17 | 7.27 | 7.155 | 7.27 | 17722.00 |
| Aug 06, 2026 | 7.14 | 7.255 | 7.09 | 7.14 | 42560.00 |
| Aug 05, 2026 | 7.25 | 7.33 | 7.17 | 7.18 | 92716.00 |
| Aug 04, 2026 | 7.23 | 7.39 | 7.22 | 7.34 | 65207.00 |
| Aug 03, 2026 | 7.09 | 7.29 | 7.09 | 7.23 | 26436.00 |
| Jul 31, 2026 | 7.17 | 7.25 | 7.111 | 7.14 | 70191.00 |
| Jul 30, 2026 | 7.06 | 7.13 | 7.04 | 7.10 | 17900.00 |
| Jul 29, 2026 | 7.04 | 7.15 | 7.00 | 7.01 | 31288.00 |
| Jul 28, 2026 | 6.91 | 7.07 | 6.89 | 7.06 | 78442.00 |
| Jul 27, 2026 | 7.00 | 7.09 | 6.93 | 6.99 | 37862.00 |
| Jul 24, 2026 | 7.01 | 7.13 | 6.99 | 7.06 | 17808.00 |
| Jul 23, 2026 | 6.96 | 7.04 | 6.924 | 6.96 | 27642.00 |
| Jul 22, 2026 | 7.09 | 7.19 | 7.00 | 7.01 | 49843.00 |
| Jul 21, 2026 | 7.25 | 7.31 | 7.17 | 7.28 | 24580.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioLineRx Ltd. | 3.00 |
| XTL Biopharmaceuticals Ltd. | 2.625 |
| Can-Fite BioPharma Ltd. | 3.35 |
| Galmed Pharmaceuticals Ltd. | 4.05 |
| Revium Recovery, Inc. | 1.43 |
Price Related Metrics
| PE Ratio | 22.09 |
| PS Ratio | 2.581 |
| PEG Ratio | 1.429 |
| Price to Book Value | 1.804 |
| Price to Free Cash Flow | 17.92 |
| Earnings Yield | 4.53% |
| Market Cap | 486.36M |
| PEGY Ratio | 1.199 |
| Operating PE Ratio | 17.80 |
| Normalized PE Ratio | 21.53 |